API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-15-2023-17266.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-lifesciences-gets-usfda-nod-to-market-generic-drug/articleshow/99054057.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-8-2023-15780.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-1-2023-82562.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-levothyroxine-sodium-oral-solution-46757.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/ibsa-pharma-inc-issues-voluntary-nationwide-recall-select-lots-tirosintr-sol-levothyroxine-sodium
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215259
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211417
https://www.fiercepharma.com/pharma/xeris-gets-green-light-take-subcutaneous-challenger-abbvie-drug-phase-2
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-levothyroxine-sodium-capsules-53428.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-levothyroxine-sodium-oral-solution-98427.pdf
https://www.reuters.com/business/healthcare-pharmaceuticals/french-drug-agency-says-under-investigation-over-thyroid-drug-2022-12-06/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217066
https://www.prnewswire.com/news-releases/new-study-confirms-that-a-commonly-used-acid-reducing-drug-does-not-interfere-with-the-absorption-of-a-novel-liquid-levothyroxine-formulation-301390136.html
https://www.prnewswire.com/news-releases/pharmacokinetic-study-confirming-the-bioequivalence-of-a-novel-oral-solution-of-levothyroxine-thyquidity-to-synthroid-presented-at-the-90th-annual-meeting-of-the-american-thyroid-association-301389437.html
https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-accord-uk-ltd-trading-style-northstar-levothyroxine-tablets-bp-50-micrograms-el-21-a-slash-23
https://www.fda.gov/consumers/consumer-updates/older-therapies-arent-necessarily-better-thyroid-hormone-replacement
https://www.prnewswire.com/news-releases/new-study-confirms-the-stability-and-potency-of-a-novel-formulation-of-liquid-levothyroxine-301280724.html
https://www.prnewswire.com/news-releases/new-study-confirms-the-stability-and-potency-of-a-novel-formulation-of-liquid-levothyroxine-301280724.html
https://www.eurekalert.org/pub_releases/2021-03/tes-cth031621.php#:~:text=Results%20of%20their%20new%20randomized,with%20levothyroxine%20alone%2C%20researchers%20say.
https://www.prnewswire.com/news-releases/vertice-launches-thyquidity-levothyroxine-sodium-oral-solution-301233874.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213256
https://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-and-vertice-co-promote-thyquiditytm-levothyroxine
https://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-and-vertice-co-promote-thyquiditytm-levothyroxine
https://www.prnewswire.com/news-releases/lannett-launches-authorized-generic-of-tirosint-levothyroxine-sodium-capsules-301165364.html
https://www.raps.org/news-and-articles/news-articles/2020/10/good-real-world-outcomes-for-generic-levothyroxine
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-23-2020-1600837535.pdf
https://www.pharmacompass.com/pdf/news/acella-pharmaceuticals-llc-issues-recall-np-thyroid15-120-due-to-sub-potency-1600842962.pdf
https://www.prnewswire.com/news-releases/lannett-and-cediprof-announce-exclusive-distribution-agreement-for-an-approved-levothyroxine-301094577.html
https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-wockhardt-uk-ltd-levothyroxine-100micrograms-5ml-oral-solution-el-20-a-04
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-tirosint-21924-levothyroxine-sodium-capsules-88-mcg-100-mcg-and-125-mcg-1569474753.pdf
https://www.prnewswire.com/news-releases/lannett-enters-into-advisory-services-agreement-with-strategic-alliance-partner-300907202.html
https://www.fiercepharma.com/pharma-asia/foreign-drugmakers-under-threat-as-china-rolls-out-drug-list-to-boost-generic
https://health.economictimes.indiatimes.com/news/pharma/lupin-launches-levothyroxine-sodium-tablets-in-us/68520116
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210831
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-26-2018-1545811500.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208749
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=11192018103541